ATLANTA--(BUSINESS WIRE)--MIV Therapeutics Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible drug-eluting stents, has released a new corporate video in which Company President Dr. Mark Landy outlines MIVT’s proprietary technologies and current product development initiatives targeting the worldwide $6 billion drug-eluting stent marketplace.
